In the BioHarmony Drug Report Database

"Preview" Icon

Fosamprenavir

Lexiva, Telzir (fosamprenavir) is a small molecule pharmaceutical. Fosamprenavir was first approved as Lexiva on 2003-10-20. It is used to treat acquired immunodeficiency syndrome in the USA. It has been approved in Europe to treat HIV infections.

 

Trade Name

 

Telzir
 

Common Name

 

fosamprenavir
 

ChEMBL ID

 

CHEMBL1664
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Antivirals: HIV protease inhibitors (saquinavir type); phosphoro-derivatives

Image (chem structure or protein)

Fosamprenavir structure rendering